Patients should feel confident and supported in their ability to manage weight and health without relying solely on medication
Administer the Injection Insert the needle : Hold the pen at a 90-degree angle to the skin
Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor triple agonist
It is not a drug, food, supplement, or cosmetic, is not approved by the FDA, and is not intended to diagnose, treat, cure, or prevent any disease, or for human or veterinary consumption
Available GLP-1 drugs At this time, for the purposes of the Medicare GLP-1 Bridge, an eligible GLP-1 drug is any of the following products when used to reduce excess body weight and maintain weight reduction: Foundayo Wegovy (injection and tablets) Zepbound (KwikPen formulation only) This list may be updated over the course of the program
Medically reviewed by Mohammed Lakhi Superintendent Pharmacist